New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Immunotherapy improves remission for relapsed, refractory leukemia: Clinical trial

Immunotherapy improves remission for relapsed, refractory leukemia: Clinical trial

by Melissa Rohman,Northwestern UniversityHigh-power magnification (1000x) of a Wright's stained peripheral blood smear showing chronic lymphocytic leukemia (CLL). The lymphocytes with the da
World medicine December 12,2023
Immunotherapy improves remission for relapsed, refractory leukemia: Clinical trial

Immunotherapy improves remission for relapsed, refractory leukemia: Clinical trial

by Melissa Rohman,Northwestern UniversityHigh-power magnification (1000x) of a Wright's stained peripheral blood smear showing chronic lymphocytic leukemia (CLL). The lymphocytes with the da
World medicine December 12,2023
Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer

Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPeople living with HIV remain at higher risk than people living without HIV for developing various cancers that can be treated with
World medicine December 12,2023
Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer

Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainPeople living with HIV remain at higher risk than people living without HIV for developing various cancers that can be treated with
World medicine December 12,2023
Mississippi's cervical cancer deaths indicate broader health care problems

Mississippi's cervical cancer deaths indicate broader health care problems

by Virginia Anderson, KFF Health NewsCredit: CC0 Public DomainShementé Jones knew something wasn't right. Her back hurt. She felt pain during sex.She said she kept telling her doctor something was
World medicine December 12,2023
Mississippi's cervical cancer deaths indicate broader health care problems

Mississippi's cervical cancer deaths indicate broader health care problems

by Virginia Anderson, KFF Health NewsCredit: CC0 Public DomainShementé Jones knew something wasn't right. Her back hurt. She felt pain during sex.She said she kept telling her doctor something was
World medicine December 12,2023
US Preventive Services Task Force: Evidence lacking for screening asymptomatic patients for skin cancer

US Preventive Services Task Force: Evidence lacking for screening asymptomatic patients for skin cancer

by Elana GotkineThe U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient for assessing the balance of benefits and harms of screening asymptomatic adults an
World medicine December 12,2023
US Preventive Services Task Force: Evidence lacking for screening asymptomatic patients for skin cancer

US Preventive Services Task Force: Evidence lacking for screening asymptomatic patients for skin cancer

by Elana GotkineThe U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient for assessing the balance of benefits and harms of screening asymptomatic adults an
World medicine December 12,2023
US Preventive Services Task Force recommends biennial screening mammography from 40 to 74

US Preventive Services Task Force recommends biennial screening mammography from 40 to 74

by Elana GotkineThe U.S. Preventive Services Task Force (USPSTF) recommends biennial screening mammography for women ages 40 to 74 years. This recommendation forms the basis of a draft recommendation
World medicine December 12,2023
US Preventive Services Task Force recommends biennial screening mammography from 40 to 74

US Preventive Services Task Force recommends biennial screening mammography from 40 to 74

by Elana GotkineThe U.S. Preventive Services Task Force (USPSTF) recommends biennial screening mammography for women ages 40 to 74 years. This recommendation forms the basis of a draft recommendation
World medicine December 12,2023
American Indian and Alaska Native men less likely to receive prostate cancer screening

American Indian and Alaska Native men less likely to receive prostate cancer screening

by Atrium Health Wake Forest BaptistCredit: Unsplash/CC0 Public DomainNew research from Wake Forest University School of Medicine shows that American Indian and Alaska Native men are less likely to be
World medicine December 12,2023
American Indian and Alaska Native men less likely to receive prostate cancer screening

American Indian and Alaska Native men less likely to receive prostate cancer screening

by Atrium Health Wake Forest BaptistCredit: Unsplash/CC0 Public DomainNew research from Wake Forest University School of Medicine shows that American Indian and Alaska Native men are less likely to be
World medicine December 12,2023
Start mammograms at 40, not 50, a US health panel recommends

Start mammograms at 40, not 50, a US health panel recommends

Credit: Pixabay/CC0 Public DomainWomen should start getting every-other-year mammograms at age 40 instead of waiting until 50, according to a draft recommendation from a federal task force.The U.S. Pr
World medicine December 12,2023
Start mammograms at 40, not 50, a US health panel recommends

Start mammograms at 40, not 50, a US health panel recommends

Credit: Pixabay/CC0 Public DomainWomen should start getting every-other-year mammograms at age 40 instead of waiting until 50, according to a draft recommendation from a federal task force.The U.S. Pr
World medicine December 12,2023
American Urological Association: Genomic urine test accurately predicts bladder cancer

American Urological Association: Genomic urine test accurately predicts bladder cancer

by Lori SolomonA new genomic urine test can predict bladder cancer as many as 12 years before clinical signs and symptoms emerge, according to a study presented at the annual meeting of the American U
World medicine December 12,2023
American Urological Association: Genomic urine test accurately predicts bladder cancer

American Urological Association: Genomic urine test accurately predicts bladder cancer

by Lori SolomonA new genomic urine test can predict bladder cancer as many as 12 years before clinical signs and symptoms emerge, according to a study presented at the annual meeting of the American U
World medicine December 12,2023
Every cancer is unique: Why different cancers require different treatments, and how evolution drives drug resistance

Every cancer is unique: Why different cancers require different treatments, and how evolution drives drug resistance

by Joshua Warrick, David DeGraff and Monika Joshi,The ConversationMost tumors are made up of many different kinds of cancer cells, as shown in this pancreatic cancer sample from a mouse. Credit:
World medicine December 12,2023
Every cancer is unique: Why different cancers require different treatments, and how evolution drives drug resistance

Every cancer is unique: Why different cancers require different treatments, and how evolution drives drug resistance

by Joshua Warrick, David DeGraff and Monika Joshi,The ConversationMost tumors are made up of many different kinds of cancer cells, as shown in this pancreatic cancer sample from a mouse. Credit:
World medicine December 12,2023
A step toward treating chemotherapy-resistant prostate cancer

A step toward treating chemotherapy-resistant prostate cancer

byAmerican Chemical SocietyCredit:ACS Central Science(2023). DOI: 10.1021/acscentsci.3c00286Prostate cancer is a leading cause of death among American men, and it's resistant to
World medicine December 12,2023
A step toward treating chemotherapy-resistant prostate cancer

A step toward treating chemotherapy-resistant prostate cancer

byAmerican Chemical SocietyCredit:ACS Central Science(2023). DOI: 10.1021/acscentsci.3c00286Prostate cancer is a leading cause of death among American men, and it's resistant to
World medicine December 12,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com